Carvedilol/Ivabradine Hydrochloride

卡维地洛/盐酸伊伐布雷定

Report date: 2023/12/14 10:53:42

Base Information

Drug NameCarvedilol/Ivabradine Hydrochloride
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockersBeta adrenergic receptors antagonistsAdrenergic receptor alpha-1 antagonists +[4] 
TargetsVoltage-gated calcium channelBeta adrenergic receptorsAdrenergic receptors alpha-1 +[4] 
Therapy Area/IndicationsCoronary DiseaseAngina, StableHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes CarvedilolIvabradine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLes Laboratoires Servier
China Registration ClassN/A

Develop Information

Active CompaniesLes Laboratoires Servier
Inactive CompaniesN/A
Active IndicationsCoronary DiseaseAngina, StableHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A